Expertise in
64
conditions

Dr. Steven A. Meckstroth

Gastroenterology
Beacon Health LLC
1656 Medical Blvd Ste 301, 
Naples, FL 
Accepting New Patients
Offers Telehealth
Expertise in
64
conditions
Beacon Health LLC
1656 Medical Blvd Ste 301, 
Naples, FL 

Overview

Steven Meckstroth is a Gastroenterologist practicing medicine in Naples, Florida.

Dr. Meckstroth is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Gastric Dysmotility, Familial Adenomatous Polyposis, Colitis, Gastrectomy, and Colonoscopy.

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Meckstroth is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in FL

Hospital Affiliations

Cape Coral Hospital
Lee Memorial Hospital
Naples Community Hospital
Physicians Regional Medical Center - Pine Ridge

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Beacon Health LLC
1656 Medical Blvd Ste 301, Naples, FL 34110
Other Locations
NCH North Naples Hospital
11190 Health Park Blvd, Naples, FL 34110

Additional Areas of Focus

Dr. Meckstroth has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
61
conditions
Dr. Alexandra R. Grace
Gastroenterology
Expertise in
61
conditions
Dr. Alexandra R. Grace
Gastroenterology
Referral may be required

Beacon Health LLC

1656 Medical Blvd Ste 301, 
Naples, FL 
 (0.1 miles away)
239-593-6201
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexandra Grace is a Gastroenterologist practicing medicine in Naples, Florida. Dr. Grace is highly rated in 61 conditions, according to our data. Her clinical expertise encompasses Barrett Esophagus, Gastroesophageal Reflux Disease (GERD), Chronic Erosive Gastritis, Gastrectomy, and Endoscopy. Dr. Grace is currently accepting new patients.

Expertise in
40
conditions
Dr. Guy R. Winzenried
Gastroenterology
Expertise in
40
conditions
Dr. Guy R. Winzenried
Gastroenterology
Referral may be required

Office

2425 Tamiami Trl N Ste 210, 
Naples, FL 
 (5.7 miles away)
239-228-6283
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Guy Winzenried is a Gastroenterologist practicing medicine in Naples, Florida. Dr. Winzenried is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Attenuated Familial Adenomatous Polyposis, Juvenile Polyposis Syndrome, Cronkhite-Canada Disease, Gastrectomy, and Colonoscopy. Dr. Winzenried is currently accepting new patients.

Expertise in
34
conditions
Expertise in
34
conditions
Referral may be required

Gastro Health LLC

7152 Coca Sabal Ln, 
Fort Myers, FL 
 (17.9 miles away)
239-939-9939
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Sofianos is a Gastroenterologist practicing medicine in Fort Myers, Florida. Dr. Sofianos is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Familial Adenomatous Polyposis, Gardner Syndrome, Turcot Syndrome, Gastrectomy, and Endoscopy. Dr. Sofianos is currently accepting new patients.

Frequently Asked Questions about Dr. Steven A. Meckstroth

How do I make an appointment with Dr. Steven A. Meckstroth?

You can book an appointment with Dr. Steven A. Meckstroth by calling their office at 239-593-6201. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven A. Meckstroth a top-rated expert for Gastric Dysmotility?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven A. Meckstroth is classified as an Distinguished expert for Gastric Dysmotility, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven A. Meckstroth specialize in?

While Dr. Steven A. Meckstroth is a Gastroenterology, they have specific expertise in Gastric Dysmotility, Familial Adenomatous Polyposis, and Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Steven A. Meckstroth accept my insurance?

Dr. Steven A. Meckstroth accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 239-593-6201 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Meckstroth's expertise for a condition
ConditionClose
    View All 34 Distinguished Conditions
    View All 30 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile